No Intention to Make an Offer for AMS

Further to the announcement on 18 April 2026 by Advanced Medical Solutions Group plc ("AMS") that funds affiliated with TA Associates (UK), LLP (together, "TA") were considering a possible offer for the entire issued and to be issued share capital of AMS, TA today confirms that it does not intend to make an offer for AMS.

TA is grateful for the engagement with the AMS Board and management team and would like to thank them for their time and consideration of this potential transaction.

This is a statement to which Rule 2.8 of the Code applies. Accordingly, TA and any person(s) acting in concert with it will, except with the consent of the Panel on Takeovers and Mergers (the "Takeover Panel"), be bound by the restrictions set out in Rule 2.8 of the Code. Under Note 2 on Rule 2.8 of the Code, TA, and any person(s) acting in concert with it, reserves the right to set the restrictions in Rule 2.8 of the Code aside in the following circumstances:

• with the agreement of the board of Directors of AMS;
• following the announcement of a firm intention to make an offer for AMS by, or on behalf of, a third party;
• following the announcement by AMS of a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Code), or a reverse takeover (as defined by the Code); or
• where the Takeover Panel has determined that there has been a material change in circumstances.